Seroba Kernel
Press Archives
2009 Press Releases
2008 Press Releases
2007 Press Releases
2006 Press Releases
2005 Press Releases
2004 Press Releases
2002 Press Releases

2009 Press
30th September
Seroba Kernel co-leads a £9 Million Financing in Quanta
19th May
Seroba Kernel confirm additional €3.3M Investment in Opsona
15th May
AGI Announces top-line results of Phase III study of Rezular™ in IBS-D
12th May
Procter & Gamble Announces National Launch of Align
12th March
AGI announces positive results in a Phase II proof of concept study of AGI-004
18th February
Opsona Therapeutics closes €18M Funding
9th February
Tánaiste Mary Coughlan Launches €75m Seroba Kernel Life Sciences Fund II Limited Partnership
4th February
Alimentary Health announces the launch of Prostora(TM) Max, a new probiotic supplement for dogs.
2nd February
Merrion Pharmaceuticals Retains Sage Group to Augment Strategic Alliance Efforts
21st January
Kernel Capital Investee Merrion Pharmaceuticals signs second $58m contract with Novo Nordisk
12th January
Alimentary Health to launch IBS treatment
1st January
Bank of Ireland Kernel Capital Fund and ETV Capital (London) Invest €1.1m in Limerick Based, Stokes Bio.
Alimentary Health announces the launch of Prostora(TM) Max, a new probiotic supplement for dogs.

Cork, Ireland, February 4th 2009: Alimentary Health the Cork based development stage specialty biotechnology company, today announces that its licensing partner, P&G Pet Care, the maker of Iams Veterinary Formulas, has announced the launch of Prostora(TM) Max, a new probiotic supplement for dogs.

Prostora(TM) Max will use Alimentary Health and P&G’s co-developed patent pending probiotic strain, Bifidobacterium animalis, which helps nutritionally managed digestive upsets, such as diarrhea and helps maintain digestive health in dogs. Prostora(TM) Max will be available through veterinarians, initially in the U.S. According to a recent Euromonitor report, the North American dog and cat food market (excluding treats) is valued at $14.7 billion and growing at 9% per annum. Alimentary Health will receive an undisclosed royalty on sales of all products containing Prostora(TM) Max.

"Probiotics are a new standard in nutritional health for restoring intestinal flora balance, improving digestive function and aiding in the relief of diarrhea" said Amy Dicke, DUM, Technical Services Veterinarian at P&G Pet Care. Dr. Barry Kiely, CEO of Alimentary Health, commented: "Today’s announcement comes as a result of our continued successful collaboration with P&G. We are pleased that our ongoing efforts have once again resulted in Alimentary Health’s technology making it to the market place."